Postprandial increase in plasma concentrations of remnant-like particles: An independent risk factor for restenosis after percutaneous coronary intervention

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 66-73

  Oi, Keiji ^a   Shimokawa, Hiroaki ^a,f   Hirakawa, Yoji ^a   Tashiro, Hideki ^b   Nakaike, Ryuichi ^c   Kozai, Toshiyuki ^d   Ohzono, Keizaburo ^e   Yamamoto, Kunihiko ^b   Koyanagi, Samon ^e   Okamatsu, Shuichi ^d   Tajimi, Tsukasa ^c   Kikuchi, Yutaka ^c   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b St Mary's Hospital   (Japan)

^c Kyushu Welfare and Pension Hospital   (Japan)

^d ASO IIZUKA HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

Angioplasty; Coronary artery disease; Remnant lipoproteins; Restenosis

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHOLESTEROL, HDL; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; POSTPRANDIAL PERIOD; RISK FACTORS; TRIGLYCERIDES;

EID: 3042785737     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00009     Document Type: Article

References (25)

1. Cohn JS, Marcoux C, Davignon J. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol. 1999;19:2474-2486.
2. Campos E, Nakajima K, Tanaka A, et al. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 1992;33:369-380.
3. Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin Chim Acta. 1993;223:53-71.
4. Nakajima K, Okazaki M, Tanaka A. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-1. J Clin Ligand Assay. 1996;19:177-183.
5. Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 1998;97:2519-2526.
6. Doi H, Kugiyama K, Ohgushi M, et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 1998;137:341-349.
7. Inoue T, Saniabadi AR, Matsunaga R, et al. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis. 1998;139:363-367.
8. Saniabadi AR, Uemura K, Shimoyama R, et al. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Haemost. 1997;77:996-1001.
9. Devaraj S, Vega G, Lange R, et al. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med. 1998;104:445-450.
10. Kugiyama K, Doi H, Takazoe K, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 1999;99:2858-2860.
11. Takeichi S, Yukawa N, Nakajima Y, et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 1999;142:309-315.
12. McNamara JR, Shah PK, Nakajima K, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from Framingham heart study. Atherosclerosis. 2001;154:229-236.
13. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, Type IIa, Type III, and Type IV hyperlipoproteinemic individuals: Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987;79:1110-1119.
14. Cohn JS, McNamara JR, Cohn SD, et al. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988;29:469-479.
15. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995;41:153-158.
16. Kuntz RE, Baim DS. Prevention of coronary restenosis: the evolving evidence base for radiation therapy. Circulation. 2000;101:2130-2133.
17. rd, Meier B. Interventional treatment of coronary heart disease and peripheral vascular disease. Circulation. 200;102:IV81-IV86.
18. Karpe F, Boquist S, Tang R, et al. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglyceride. J Lipid Res. 2001;42:17-21.
19. Leary ET, Wang T, Baker DJ, et al. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem. 1998;44:2490-2498.
20. Kishi K, Ochiai K, Ohta Y, et al. Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum. Clin Chem. 2002;48:737-741.
21. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512-1521.
22. Okazaki M, Usui S, Tada N, et al. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta. 2000;296:135-149.
23. Tomono S, Kawazu S, Kato N, et al. Uptake of remnant-like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb. 1994;1:98-102.
24. Tamura M, Tanaka A, Yui K, et al. Oxidation of remnant-like particles from serum of diabetic patients, patients with ischemic disease and normal subjects. Horm Metab Res. 1997;29:398-402.
25. McNamara JR, Sha PK, Nakajima K, et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart study. Clin Chem. 1998;44:1224-1232.